| Date Filed | Type | Description |
| 05/19/2020 |
4
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Bought 4,200 shares
@ $1.2076, valued at
$5.1k
Bought 1,600 warrants
@ $6.4575, valued at
$10.3k
|
|
| 05/18/2020 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/08/2020 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2020 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/13/2020 |
10-Q
| Quarterly Report for the period ended February 29, 2020 |
| 04/13/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/11/2020 |
8-K
| Quarterly results |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/07/2020 |
8-K
| Other Events |
| 02/04/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/14/2020 |
10-Q
| Quarterly Report for the period ended November 30, 2019 |
| 01/14/2020 |
8-K
| Quarterly results |
| 01/03/2020 |
SC 13G/A
| Alinga Capital LLC reports a 2.3% stake in Artelo Biosciences Inc. |
| 12/18/2019 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 12/17/2019 |
10-K/A
| Annual Report for the period ended August 31, 2019 [amend] |
| 12/13/2019 |
4
| Beck John W (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 40,000 options to buy
@ $2.65, valued at
$106k
Granted 10,000 options to buy
@ $2.65, valued at
$26.5k
|
|
| 12/13/2019 |
3
| Beck John W (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 12/06/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/25/2019 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 11/25/2019 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 11/25/2019 |
10-K
| Annual Report for the period ended August 31, 2019 |
| 11/15/2019 |
8-K
| Quarterly results |
| 11/05/2019 |
4
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Bought 2,400 shares
@ $2.2098, valued at
$5.3k
|
|
| 11/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/29/2019 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 10/17/2019 |
4
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Bought 2,600 shares
@ $2.051, valued at
$5.3k
|
|
| 10/11/2019 |
4
| Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Bought 2,700 shares
@ $1.9613, valued at
$5.3k
|
|
| 09/06/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/30/2019 |
4
| Kelly Steven (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 22,250 options to buy
@ $1.99, valued at
$44.3k
|
|
|